M. Balasegaram, K. Ritmeijer, M. A. Lima, S. Burza, G. Ortiz-genovese et al., Liposomal amphotericin B as a treatment for human leishmaniasis, Expert Opinion on Emerging Drugs, vol.17, 2012.

N. S. Carter, P. A. Yates, S. K. Gessford, S. R. Galagan, S. M. Landfear et al., Adaptive responses to purine starvation in Leishmania donovani, Molecular Microbiology, vol.78, pp.92-107, 2010.

S. L. Croft and P. Olliaro, Leishmaniasis chemotherapy-challenges and opportunities, Clinical Microbiology and Infection, vol.17, 2011.

S. L. Croft, S. Sundar, and A. H. Fairlamb, Drug resistance in leishmaniasis, Clinical Microbiological Reviews, vol.19, pp.111-126, 2006.

D. Koning, H. P. Bridges, D. J. Burchmore, and R. J. , Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy, FEMS Microbiology Reviews, vol.29, 2005.

T. P. Dorlo, M. Balasegaram, J. H. Beijnen, and P. J. De-vries, Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis, Journal of Antimicrobial Chemotherapy, vol.67, pp.2576-2597, 2012.

B. I. Eklund, M. Moberg, J. Bergquist, and B. Mannervik, Divergent activities of human glutathione transferases in the bioactivation of azathioprine, Molecular Pharmacology, vol.70, pp.747-754, 2006.

A. M. Farca, B. Miniscalco, P. Badino, R. Odore, P. Monticelli et al., Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum, Parasitology Research, vol.110, 2012.

E. O. Freitas, D. Nico, R. Guan, J. R. Meyer-fernandes, K. Clinch et al., Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication in vitro, PLoS One, vol.10, 2015.

P. Lawton, C. Hejl, R. Mancassola, M. Naciri, and A. F. Petavy, Effects of purine nucleosides on the in vitro growth of Cryptosporidium parvum, FEMS Microbiology Letters, vol.226, pp.39-43, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02110999

A. E. Leroux and R. L. Krauth-siegel, Thiol redox biology of Trypanosomatids and potential targets for chemotherapy, Molecular and Biochemical Parasitology, 2015.

J. L. Martin, P. A. Yates, R. Soysa, J. F. Alfaro, F. Yang et al., Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani, PLoS Pathogens, vol.10, 2014.

S. Mondal, J. J. Roy, and T. Bera, Generation of adenosine tri-phosphate in Leishmania donovani amastigote forms. Acta Parasitologica, vol.59, pp.11-16, 2014.

B. Monge-maillo and R. López-vélez, Therapeutic options for visceral leishmaniasis, Drugs, vol.73, 2013.

J. Pachioni, A. De, J. G. Magalhães, E. J. Lima, L. Bueno et al., Alkylphospholipids -a promising class of chemotherapeutic agents with a broad pharmacological spectrum, Journal of Pharmacy and Pharmaceutical Sciences, vol.16, 2013.

T. D. Serafim, A. B. Figueiredo, P. A. Costa, E. A. Marques-da-silva, R. Gonçalves et al., Leishmania metacyclogenesis is promoted in the absence of purines, PLoS Neglected Tropical Diseases, vol.6, 2012.

, Accepted for publication, 2017.

L. Solano-gallego, G. Miró, A. Koutinas, L. Cardoso, M. G. Pennisi et al., LeishVet guidelines for the practical management of canine leishmaniosis, Parasites & Vectors, vol.4, pp.86-102, 2011.

R. Soysa, Z. N. Wilson, J. Elferich, I. Forquer, U. Shinde et al., Substrate inhibition of uracil phosphoribosyltransferase by uracil can account for the uracil growth sensitivity of Leishmania donovani pyrimidine auxotrophs, Journal of Biological Chemistry, vol.288, 2013.

S. Sundar and J. Chakravarty, Leishmaniasis: an update of current pharmacotherapy, Expert Opinion on Pharmacotherapy, vol.14, 2013.

I. M. Vincent and M. P. Barrett, Metabolomic-based strategies for anti-parasite drug discovery, Journal of Biomolecular Screening, vol.20, pp.44-55, 2015.